182 related articles for article (PubMed ID: 15879000)
21. Roles of organic anion transporters in the progression of chronic renal failure.
Enomoto A; Niwa T
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
[TBL] [Abstract][Full Text] [Related]
22. Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.
Russel FG; Wouterse AC; van Ginneken CA
J Pharmacol Exp Ther; 1989 Jan; 248(1):436-46. PubMed ID: 2913287
[TBL] [Abstract][Full Text] [Related]
23. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
[TBL] [Abstract][Full Text] [Related]
24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
25. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
26. Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats.
Windt WA; Henning RH; Kluppel AC; Xu Y; de Zeeuw D; van Dokkum RP
Nephrol Dial Transplant; 2008 Oct; 23(10):3103-10. PubMed ID: 18503101
[TBL] [Abstract][Full Text] [Related]
27. The kidney and uremic toxin removal: glomerulus or tubule?
Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
[TBL] [Abstract][Full Text] [Related]
28. Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines.
Russell FG; Wouterse AC; van Ginneken CA
J Pharmacol Exp Ther; 1989 Jan; 248(1):428-35. PubMed ID: 2913286
[TBL] [Abstract][Full Text] [Related]
29. Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride].
Matsumoto S; Yoshida K; Ishiguro N; Maeda T; Tamai I
J Pharmacol Exp Ther; 2007 Sep; 322(3):1246-52. PubMed ID: 17556638
[TBL] [Abstract][Full Text] [Related]
30. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate.
Takeuchi A; Masuda S; Saito H; Doi T; Inui K
Kidney Int; 2001 Sep; 60(3):1058-68. PubMed ID: 11532100
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of intestinal drug transporters in chronic renal failure in rats.
Naud J; Michaud J; Boisvert C; Desbiens K; Leblond FA; Mitchell A; Jones C; Bonnardeaux A; Pichette V
J Pharmacol Exp Ther; 2007 Mar; 320(3):978-85. PubMed ID: 17135344
[TBL] [Abstract][Full Text] [Related]
32. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
Robertson EE; Rankin GO
Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
[TBL] [Abstract][Full Text] [Related]
33. [Renal clearance of hippurate in persons with chronic renal insufficiency].
Schück O; Spustová V; Dzúrik R; Teplan V; Nádvorníková H; Skibová J
Vnitr Lek; 1994 Jul; 40(7):407-10. PubMed ID: 8073654
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.
Ji L; Masuda S; Saito H; Inui K
Kidney Int; 2002 Aug; 62(2):514-24. PubMed ID: 12110012
[TBL] [Abstract][Full Text] [Related]
35. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
[TBL] [Abstract][Full Text] [Related]
36. Harnessing transporters to clear uremic toxins.
Moe OW
J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
[No Abstract] [Full Text] [Related]
37. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
38. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure.
Satoh M; Hayashi H; Watanabe M; Ueda K; Yamato H; Yoshioka T; Motojima M
Nephron Exp Nephrol; 2003; 95(3):e111-8. PubMed ID: 14646363
[TBL] [Abstract][Full Text] [Related]
39. Protective role of gamma-aminobutyric acid against chronic renal failure in rats.
Sasaki S; Yokozawa T; Cho EJ; Oowada S; Kim M
J Pharm Pharmacol; 2006 Nov; 58(11):1515-25. PubMed ID: 17132215
[TBL] [Abstract][Full Text] [Related]
40. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats.
Hasegawa T; Nadai M; Wang L; Takayama Y; Kato K; Nabeshima T; Kato N
Drug Metab Dispos; 1994; 22(1):8-13. PubMed ID: 8149895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
